Streck 218976 Cell-Free RNA BCT®血浆游离RNA采血管

Streck 218976 Cell-Free RNA BCT®血浆游离RNA采血管

价格: 询价

品牌:STRECK

货号: 218976

收藏

产品详情

相关推荐

库存 :99

供应商 :北京云肽生物科技有限公司

Streck 218976 Cell-Free RNA BCT®血浆游离RNA采血管
Streck的专利稳定解决方案组合使科学家能够减轻和限制关键样品的分析前变化,减轻处理问题,并允许室温储存、无冷链运输和批量处理。我们的直接抽取采血管和生物流体保存产品在世界范围内得到认可。目标分析物包括无细胞DNA、无细胞RNA、分化抗原簇、细胞外囊泡和细胞核酸。
体外RNA极易降解,用特殊的采血管收集RNA样本,可以在采集同时稳定保护RNA.选用不同的采血管可以分别采集并保存:全血RNA和血浆游离RNA.。
我们北京云肽生物科技有限公司作为Streck公司的特约经销商为客户提供,正规进口,保证原装正品,货期稳定,折扣好的服务标准。
Streck 218976 Cell-Free RNA BCT®血浆游离RNA采血管,产品简介:
产品品牌:Streck
产品名称:Cell-Free RNA BCT®血浆游离RNA采血管
产品货号:218976
产品规格:100管/盒


Streck 218976 Cell-Free RNA BCT®血浆游离RNA采血管,产品说明:
Streck Cell-Free RNA BCT血浆游 离RNA采血管可以直接抽取全血,采集并稳定血浆游离RNA,以及储存运输。能防止样品处理和贮存过程中的血细胞非目标背最RNA的释放。注:本产品仅可用于科学研究,不可用于医学诊断。
无细胞DNA BCT®
用于体外诊断
无细胞DNA BCT是一种直接抽取的静脉全血采集设备,用于收集、稳定和运输静脉全血样本,用于与无细胞DNA下一代测序液体活组织检查一起使用,该方法已被批准用于无细胞DNA BCT设备中采集的样本
Streck Cell-Free RNA BCT blood collection tube血浆游离RNA采血管可以直接抽取全血,采集并稳定血浆游离RNA,以及储存运输。能防止样品处理和贮存过程中的血细胞非目标背景RNA的释放。注:本产品仅可用于科学研究,不可用于医学诊断。
Streck 218976 Cell-Free RNA blood collection tube 血浆游离RNA采血管概要和原则
  • 可以通过样品处理,运输和加工来影响cf-RNA的准确分析,从而导致裂解的有核血细胞和随后的细胞RNA释放。此外,由于...引起的cf-RNA降解核酸酶活性可能有问题。
  • 包含在Streck's Cell-Free RNA BCT中的防腐剂可防止有核血细胞释放细胞RNA,并抑制核酸酶介导的cf-RNA降解,有助于整体两个cfRNA1,2,3和细胞RNA的稳定。
  • Streck 218976 Cell-Free RNA BCT增强了cf-RNA和细胞RNA的纯化,检测和分析。样本收集在Streck 218976 Cell-Free RNA BCT在18°C至25°C之间的温度下稳定长达7天,方便样品收集,运输和储存。
 
Streck 218976 Cell-Free RNA blood collection tube 血浆游离RNA采血管所含试剂
Streck 218976 Cell-Free RNA BCT含有抗凝血剂K3EDTA,核酸酶抑制剂,代谢抑制剂和细胞防腐剂在液体介质中。
注意:Streck 218976 Cell-Free RNA BCT中的试剂表现为红色是正常现象。
 
Streck 218976 Cell-Free RNA blood collection tube 血浆游离RNA采血管,注意事项
  1. 仅供研究使用。不用于诊断程序。
  2. 不要将细胞冻结在Streck 218976 Cell-Free RNA BCT中,因为会导致破裂。
  3. 到期后不要使用管子。
  4. 不要使用管子收集要注入患者的物质。
  5. 产品预计供应使用。不要将其他组分稀释或添加到Streck 218976 Cell-Free RNA BCT中。
  6. 过量填充或灌装不足的管会导致不正确的血液与添加剂的比例,并可能导致不正确分析结果或产品性能差。
 
该装置的性能特征仅在Guardant360 CDx分析上确定。
【STRECK 218976Cell-Free RNA BCT血浆游离RNA采血管 产品英文介绍】
Streck 218976 Cell-Free RNA BCT Blood Collection Tube
Cell-Free RNA BCT isa blood collection tube with a patented preservative which stabilizes cell-free RNA in plasma and prevents the release of non-target background RNA from blood cells during sample processing and storage.
Cell-Free RNA BCT Blood Collection Tube reduces the need for immediate plasma preparation due to its unique stabilization properties. Cell-Free RNA is stable for up to 7 days at room temperature, allowing convenient sample collection, transport and storage.
STRECK Cell-Free RNA BCT Catalog Number
STRECKCell-Free RNA BCT 6-Tube Pack (RUO) 218975
STRECKCell-Free RNA BCT 100-Tube Box (RUO)218976
For Research Use Only. Not for use in diagnostic procedures in the U.S.
Streck 品牌其他热销产品:
Streck 液态活检系列产品
名称 规格 货号
Cell-Free DNA BCT 6-Tube Pack(10ml) 218961
100-Tube Pack(10ml) 218962
6-Tube Pack(2ml) 230242
100-Tube Pack(2ml) 230243
Cell-Free RNA BCT 6-Tube Pack 218975
100-Tube Pack 218976
Cell-Free DNA Urine Preserve 20×5ml 230216
5×5ml 230230


现货供应:美国Streck 218962 Cell-Free DNA BCTBlood Collection TubeDNA基因检测无创采血管
美国Streck 218976 Cell-Free RNA BCTBlood Collection Tube基因检测无创采血管,
Streck Cell-Free DNA Urine Preserve游离DNA尿液保存管规格:100管/盒,应用于:唐氏无创筛查采血管,游离DNA采血管,游离RNA采血管等等。
BD 362761 Vacutainer® CPT™ Cell Preparation Tube 肝素钠单核细胞制备管/采血管,60支/盒。
BD Vacutainer® 静脉真空采血系统 -- 标本分析前处理系统产品
BD Vacutainer® 静脉真空采血系统可用于在完全封闭状态采集、运输和处理临床科研及实验室所需的各种全血、血清或血浆标本。BD Vacutainer® 静脉真空采血管能有效减少标本的分析前误差,提高检测结果准确性,加强医院综合诊断治疗水平,严格控制血源性传染病的院内感染。同时减轻医务人员工作量,降低患者治疗成本,提高医院的综合效益。

Streck218976Cell-FreeRNA BCT游离RNA样本收集管

概要和原则
1.可以通过样品处理,运输和加工来影响cf-RNA的准确分析,从而导致裂解的有核血细胞和随后的细胞RNA释放。此外,由于...引起的cf-RNA降解核酸酶活性可能有问题。
2.包含在Streck's Cell-Free RNA BCT中的防腐剂可防止有核血细胞释放细胞RNA,并抑制核酸酶介导的cf-RNA降解,有助于整体两个cfRNA1,2,3和细胞RNA的稳定
3.Streck218976Cell-FreeRNA BCT增强了cf-RNA和细胞RNA的纯化,检测和分析。样本收集在Streck218976Cell-FreeRNA BCT在18°C至25°C之间的温度下稳定长达7天,方便样品收集,运输和储存。
试剂
Streck218976Cell-FreeRNA BCT含有抗凝血剂K3EDTA,核酸酶抑制剂,代谢抑制剂和细胞防腐剂在液体介质中。
注意:Streck218976Cell-FreeRNA BCT中的试剂表现为红色是正常现象。
注意事项
1.仅供研究使用。不用于诊断程序。
2.不要将细胞冻结在Streck218976Cell-FreeRNA BCT中,因为会导致破裂。
3.到期后不要使用管子。
4.不要使用管子收集要注入患者的物质。
5.产品预计供应使用。不要将其他组分稀释或添加到Streck218976Cell-FreeRNA BCT中。
6.过量填充或灌装不足的管会导致不正确的血液与添加剂的比例,并可能导致不正确分析结果或产品性能差。
警告
a.玻璃易碎,处理时应采取预防措施。
b.所有与它们接触的所有生物标本和材料都被认为是生物危害,应该被视为能够传播感染,按照生物安全法规处理,避免与皮肤和粘膜接触。
c.产品应与传染性医疗废物一起处置。
d.通过轻轻地将塞子从一侧摇动到另一侧或通过抓住来取出并重新插入塞子同时扭转和拉动。用于止动器拆卸的“拇指滚动”程序不推荐,可能导致管破裂和损伤。
存储和稳定性
1.在18°C至30°C储存时,空白的Streck218976Cell-FreeRNA BCT在有效期内稳定。
2.空载Streck218976Cell-FreeRNA BCT长达14天的时间,从2°C至40°C的短期储存是可以接受的。
3.不要冻结未经充填的Streck218976Cell-FreeRNA BCT。极端运输可能需要适当的绝缘
温度条件。
4.在Streck218976Cell-FreeRNA BCT中收集的血液样品在储存之前可以稳定长达7天
18°C至25°C。
产品检测说明
1.多浑浊或沉淀可见。
2.如果发生产品恶化的迹象,请联系Streck技术服务部门
使用说明
1.根据CLSI GP41-A65静脉穿刺收集标本。
防止回流 - 由于Streck218976Cell-FreeRNA BCT含有化学添加剂,重要的是避免可能从管回流。
为防止回流,请遵守以下注意事项:
a.在收集过程中,将患者的手臂置于向下的位置。
b.将止动器的管子保持在zuigao位置,以使管内容物不接触止动器或样品收集期间针头的末端。
c.一旦血液开始流入管子,或者在2分钟内才能释放止血带。
2.遵循CL41 GP41-A65中概述的排列顺序的建议。可以绘制Streck218976Cell-FreeRNA BCT后EDTA管和氟化草酸盐(糖酵解抑制剂)管。如果是Streck218976Cell-FreeRNA BCT管立即按照抽取顺序的肝素管,Streck建议收集非添加剂或EDTA在Streck218976Cell-FreeRNA BCT中收集之前,将其作为废液管。
3.完全填充管。
4.从适配器上取下管子,并轻轻搅拌8〜10次。不足或延迟混合可能导致不正确的分析结果或差的产品性能。一次反转是一个完整的转折的手腕,180度和背面
5.在推荐的温度范围内收集,运输和储存管子。
注意:
1.为获得最佳效果,建议使用21G或22G针头。当使用较小的规格针时,可能会观察到较慢填充时间。
2.当使用用于静脉穿刺的翼状(蝴蝶)收集套装,Streck Cell-Free RNA BCT是第一个拉伸管,先应该部分拉出非添加剂或EDTA废弃管,以消除空气或“死空间”从管道。
RNA提取
无细胞血浆RNA和细胞RNA的提取可以使用包括蛋白酶K处理步骤的大多数市售试剂盒来完成。
无细胞血浆RNA步骤1.为了分离血浆,在室温下以300×g离心全血20分钟。步骤2.取下上层等离子体层并转移到新的锥形管(未提供)。步骤3.以5000xg离心等离子体10分钟。步骤4.每个试剂盒制造商说明隔离无细胞RNA。为了获得最佳结果,在提取无细胞RNA时,在离液盐存在下,在60℃下,包括蛋白酶K处理步骤(≥30mAU/ mL消化)1小时。
细胞RNA步骤
1.为了分离白细胞,要么将红细胞裂解并洗涤,要么离心全血并收集血沉棕黄层。步骤
2.分离每个试剂盒制造商说明书的基因组RNA。为了获得最佳结果,在提取细胞基因组RNA时,在离液盐存在下,在60℃下,包括蛋白酶K处理步骤(≥30mAU/ mL消化)2小时。
注意:
1.无细胞RNA BCT不稀释血液样品;因此,不需要稀释因子校正。
2.与大多数临床实验室标本一样,溶血,黄疸和脂血症可能影响用无细胞RNA BCT保存的血液样品获得的结果。
英文介绍
Cell-Free RNA BCT ®
INSTRUCTIONS FOR USE
Cell-Free RNA BCT® is a direct-draw whole blood collection tube intended for collection, stabilization and transportation of cell-free plasma RNA. Cell-Free RNA BCT also stabilizes and preserves cellular RNA in white blood cells. This product has not been cleared by the U.S. Food and Drug Administration for In Vitro Diagnostic Use. The product is For Research Use Only. Not for use in diagnostic procedures.
SUMMARY AND PRINCIPLES
Accurate analysis of cf-RNA can be compromised by sample handling, shipping and processing, causing lysis of nucleated blood cells and subsequent release of cellular RNA. Additionally, degradation of cf-RNA due to nuclease activity can be problematic.
The preservative reagent contained in Streck’s Cell-Free RNA BCT stabilizes nucleated blood cells, preventing the release of cellular RNA, and inhibits nuclease mediated degradation of cf-RNA, contributing to the overall stabilization of both cfRNA1,2,3 and cellular RNA.4
Cell-Free RNA BCT enhances purification, detection and analysis of cf-RNA and cellular RNA. Samples collected in Cell-Free RNA BCT are stable for up to 7 days at temperatures between 18 °C to 25 °C, allowing convenient sample collection, transport and storage.
REAGENTS
Cell-Free RNA BCT contains the anticoagulant K3EDTA, nuclease inhibitors, metabolic inhibitors and a cell preservative in a liquid medium.
Note: It is normal for the reagent in Cell-Free RNA BCT to have a reddish appearance.
PRECAUTIONS
1. For Research Use Only. Not for use in diagnostic procedures.
2. Do not freeze specimens in Cell-Free RNA BCT as breakage could result.
3. Do not use tubes after expiration date.
4. Do not use tubes for collection of materials to be injected into patients.
5. Product is intended for use as supplied. Do not dilute or add other components to Cell-Free RNA BCT.
6. Overfilling or underfilling of tubes will result in an incorrect blood-to-additive ratio and may lead to incorrect analytic results or poor product performance.
CAUTION
a. Glass has the potential for breakage; precautionary measures should be taken during handling.
b. All biological specimens and materials coming in contact with them are considered biohazards and should be treated as if capable of transmitting infection. Dispose of in accordance with federal, state and local regulations. Avoid contact with skin and mucous membranes.
c. Product should be disposed with infectious medical waste.
d. Remove and reinsert stopper by either gently rocking the stopper from side to side or by grasping with a simultaneous twisting and pulling action. A “thumb roll”procedure for stopper removal is NOT recommended as tube breakage and injury may result.
7.SDS can be obtained at www.streck.com or by calling 800-843-0912.
STORAGE AND STABILIT
1. When stored at 18 °C to 30 °C, empty Cell-Free RNA BCT is stable through expiration date.
2. Short-term storage from 2 °C to 40 °C is acceptable for empty Cell-Free RNA BCT for up to 14 days.
3. Do not freeze unfilled Cell-Free RNA BCT. Proper insulation may be required for shipment during extreme temperature conditions.
4. Blood samples collected in Cell-Free RNA BCT are stable for up to 7 days when stored between 18 °C to 25 °C.
INDICATIONS OF PRODUCT DETERIORATION
1. Cloudiness or precipitate visible.
2. If indications of product deterioration occur, contact Streck Technical Services at 800-843-0912 or technicalservices@streck.com.
INSTRUCTIONS FOR USE
For a video demonstration, visit www.streck.com/mixing.
1. Collect specimen by venipuncture according to CLSI GP41-A65.
Prevention of Backflow - Since Cell-Free RNA BCT contains chemical additives, it is important to avoid possible backflow from the tube.
To guard against backflow, observe the following precautions:
a. Keep patient’s arm in the downward position during the collection procedure.
b. Hold the tube with the stopper in the uppermost position so that the tube contents do not touch the stopper or the end of the needle during sample collection.
c. Release tourniquet once blood starts to flow in the tube, or within 2 minutes of application.
2. Follow recommendations for order of draw outlined in CLSI GP41-A65. Cell-Free RNA BCT can be drawn after the EDTA tube and before the fluoride oxalate (glycolytic inhibitor) tube. If a Cell-Free RNA BCT tube immediately follows a heparin tube in the draw order, Streck recommends collecting a non-additive or EDTA tube as a waste tube prior to collection in the Cell-Free RNA BCT.
3. Fill tube completely.
4. Remove tube from adapter and immediately mix by gentle inversion 8 to 10 times. Inadequate or delayed mixing may result in incorrect analytical results or poor product performance. One inversion is a complete turn of the wrist, 180 degrees, and back per the figure below:
5. After collection, transport and store tubes within the recommended temperature range.
Note:
1. For best results, a 21G or 22G needle is advised. Slower fill times may be observed when using a smaller gauge needle.
2. When using a winged (butterfly) collection set for venipuncture and the Streck Cell-Free RNA BCT is the first tube drawn, a non-additive or EDTA discard tube should be partially drawn first in order to eliminate air or “dead space”from the tubing.
RNA EXTRACTION
Extraction of cell-free plasma RNA and cellular RNA can be accomplished using most commercially available kits that include a Proteinase K treatment step.
Cell-free Plasma RNA Step 1. To separate plasma, centrifuge whole blood at 300 x g for 20 minutes at room temperature. Step 2. Remove the upper plasma layer and transfer to a new conical tube (not provided). Step 3. Centrifuge the plasma at 5000 x g for 10 minutes. Step 4. Isolate cell-free RNA per kit manufacturer instructions. For optimal results, include a Proteinase K treatment step (≥30 mAU/mL digest) at 60 °C in the presence of chaotropic salts for 1 hour when extracting cell-free RNA.
Cellular RNA Step 1. To separate the white blood cells, either lyse the red blood cells and wash, or centrifuge whole blood and collect the buffy coat layer. Step 2. Isolate genomic RNA per kit manufacturer instructions. For optimal results, include a Proteinase K treatment step (≥ 30 mAU/mL digest) at 60 °C in the presence of chaotropic salts for 2 hours when extracting cellular genomic RNA.
Note:
1. Cell-Free RNA BCT does not dilute blood samples; therefore, no dilution factor correction is necessary.
2. As in the case with most clinical laboratory specimens, hemolysis, icterus and lipemia may affect the results obtained on blood samples preserved with Cell-Free RNA BCT.
以下是Streck 218976 Cell-Free RNA blood collection tube 血浆游离RNA采血管,同类产品型号:
品牌 货号 名称 规格
Streck 218962 Cell-Free DNA血浆游离DNA采血管 100管/盒
Streck 230253 Cell-Free DNA血浆游离DNA采血管(混合塑料) 100管/盒
Streck 218976 Cell-Free RNA BCT® 血浆游离RNA样品收集管 100管/盒
Streck 230216 Cell-Free DNA Urine Preserve游离DNA尿液保存管 20x5mL
Streck 230230 Cell-Free DNA Urine Preserve游离DNA尿液保存管 5X5mL
Streck 230306 4.0mL CYTO-CHEX® BCT 4.0mL全血标本保鲜管 100管/盒
BD 367957 3.5mL血清分离胶管,SSTTI分离胶、促凝剂,
金黄色安全盖
100支/包,1000支/箱
BD 367955 5.0mL血清分离胶管,SSTTI分离胶、促凝剂,
金黄色安全盖
100支/包,1000支/箱
BD 367812 4.0mL血清管,促凝剂,红色安全盖 100支/包,1000支/箱
BD 367874  10.0mL肝素钠管,150USP单位肝素钠 绿色一-般盖 100支/包,1000支/箱
BD 367878 6.0mL肝素钠管,90USP单位肝素钠,绿色安全盖 100支/包,1000支/箱
BD 367884 4.0mL肝素锂管,60USP单位肝素锂,绿色安全盖 100支/包,1000支/箱
BD 367886 6.0mL肝素锂管,90USP单位肝素锂,绿色安全盖 100支/包,1000支/箱
BD 367863 6.0mL EDTA血常规管,K2EDTA,紫色安全盖 100支/包,1000支/箱
BD 367525 10.0mL EDTA血常规管,K2EDTA,紫色安全盖 100支/包,1000支/箱
BD 367841 2.0mL EDTA血常规管,K2EDTA ,紫色安全盖 100支/包,1000支/箱
BD 367856 3.0mL EDTA血常规管,K2EDTA,紫色安全盖 100支/包,1000支/箱
BD 367861 4.0mL EDTA血常规管,K2EDTA,紫色安全盖 100支/包,1000支/箱
BD 364606 8.5mL ACD全血玻璃管,A型ACD溶液:枸橼三钠、
枸橼酸、右旋葡萄糖,黄色一般盖
100支/盒,1000支/箱
BD 362788 5.0mL血浆准备管,K2EDTA分离胶,白色安全盖 1000支/箱
BD 362753 8.0mL单核细胞准备管, 至少120USP单位的肝素钠,红/绿一般盖 60支/箱
BD 362761 8.0mL单核细胞准备管,0.100M的柠檬酸钠1.0mL,浅蓝/黑色- -般盖 60支/箱
BD 762165 2.5mL全血RNA管,6.9mL添加剂,红色安全盖 100支/箱
BD 366448 8.5mL采血量( 3.5mL血浆体积) P100采血管15. 8mgK2EDTA,特制蛋白质稳定剂(冻干),红色安全盖 24支/箱
BD 366420 2.0mL P800采血管,DPP-IV、 酯酶、蛋白酶抑制剂混合添加剂,3.6mg K2EDTA ,半透明安全盖 100支/箱
BD 366421 8.5mL P800采血管,DPP-IV、酯酶、蛋白酶抑制剂混合添加剂,15.3mg K2EDTA,半透明安全盖 100支/箱
BD 367237 BD Vacutainer一次性使用采血组件 200个/箱
BD 367238 BD Vacutainer一次性使用采血组件 200个/箱

 

北京云肽生物科技有限公司

实名认证

金牌会员

入驻年限:3年

联系人:户经理

地址:北京

电话联系

立即询价

换一个